JP2020527594A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527594A5 JP2020527594A5 JP2020503018A JP2020503018A JP2020527594A5 JP 2020527594 A5 JP2020527594 A5 JP 2020527594A5 JP 2020503018 A JP2020503018 A JP 2020503018A JP 2020503018 A JP2020503018 A JP 2020503018A JP 2020527594 A5 JP2020527594 A5 JP 2020527594A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- pharmaceutical combination
- bst1
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1711785.4 | 2017-07-21 | ||
| GBGB1711785.4A GB201711785D0 (en) | 2017-07-21 | 2017-07-21 | Antibodies |
| PCT/EP2018/069768 WO2019016371A1 (en) | 2017-07-21 | 2018-07-20 | PHARMACEUTICAL ASSOCIATIONS COMPRISING ANTI-BST-1 ANTIBODY AND A CYTIDINE ANALOG |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020527594A JP2020527594A (ja) | 2020-09-10 |
| JP2020527594A5 true JP2020527594A5 (https=) | 2021-08-19 |
Family
ID=59771583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503018A Withdrawn JP2020527594A (ja) | 2017-07-21 | 2018-07-20 | 抗ｂｓｔ−１抗体及びシチジン類似体を含む医薬組合せ |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20200231694A1 (https=) |
| EP (1) | EP3655033A1 (https=) |
| JP (1) | JP2020527594A (https=) |
| KR (1) | KR20200032162A (https=) |
| CN (1) | CN111132697A (https=) |
| AR (1) | AR112460A1 (https=) |
| AU (1) | AU2018303241A1 (https=) |
| BR (1) | BR112020001320A2 (https=) |
| CA (1) | CA3070264A1 (https=) |
| CL (1) | CL2020000175A1 (https=) |
| CO (1) | CO2020001792A2 (https=) |
| EA (1) | EA202090333A1 (https=) |
| GB (1) | GB201711785D0 (https=) |
| IL (1) | IL272096A (https=) |
| MA (1) | MA49627A (https=) |
| MX (1) | MX2020000752A (https=) |
| PH (1) | PH12020550024A1 (https=) |
| SG (1) | SG11202000390TA (https=) |
| TW (1) | TW201907952A (https=) |
| UY (1) | UY37815A (https=) |
| WO (1) | WO2019016371A1 (https=) |
| ZA (1) | ZA202000881B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201809746D0 (en) * | 2018-06-14 | 2018-08-01 | Berlin Chemie Ag | Pharmaceutical combinations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004063494A1 (de) * | 2004-12-23 | 2006-07-13 | Tegenero Ag | Antikörper |
| UA114478C2 (uk) * | 2011-06-28 | 2017-06-26 | Берлін-Хемі Аг | Антитіло, яке специфічно зв'язується з bst1 |
| GB201806084D0 (en) * | 2018-04-13 | 2018-05-30 | Berlin Chemie Ag | Antibodies |
| CN114555123B (zh) * | 2019-10-18 | 2024-04-02 | 四十七公司 | 用于治疗骨髓增生异常综合征和急性髓系白血病的联合疗法 |
-
2017
- 2017-07-21 GB GBGB1711785.4A patent/GB201711785D0/en not_active Ceased
-
2018
- 2018-07-20 TW TW107125058A patent/TW201907952A/zh unknown
- 2018-07-20 UY UY0001037815A patent/UY37815A/es not_active Application Discontinuation
- 2018-07-20 EP EP18746656.0A patent/EP3655033A1/en not_active Withdrawn
- 2018-07-20 AR ARP180102042 patent/AR112460A1/es not_active Application Discontinuation
- 2018-07-20 MA MA049627A patent/MA49627A/fr unknown
- 2018-07-20 CN CN201880060959.0A patent/CN111132697A/zh active Pending
- 2018-07-20 SG SG11202000390TA patent/SG11202000390TA/en unknown
- 2018-07-20 MX MX2020000752A patent/MX2020000752A/es unknown
- 2018-07-20 WO PCT/EP2018/069768 patent/WO2019016371A1/en not_active Ceased
- 2018-07-20 US US16/632,195 patent/US20200231694A1/en not_active Abandoned
- 2018-07-20 BR BR112020001320-0A patent/BR112020001320A2/pt not_active IP Right Cessation
- 2018-07-20 CA CA3070264A patent/CA3070264A1/en active Pending
- 2018-07-20 AU AU2018303241A patent/AU2018303241A1/en not_active Abandoned
- 2018-07-20 EA EA202090333A patent/EA202090333A1/ru unknown
- 2018-07-20 JP JP2020503018A patent/JP2020527594A/ja not_active Withdrawn
- 2018-07-20 KR KR1020207005030A patent/KR20200032162A/ko not_active Withdrawn
-
2020
- 2020-01-16 IL IL272096A patent/IL272096A/en unknown
- 2020-01-16 PH PH12020550024A patent/PH12020550024A1/en unknown
- 2020-01-20 CL CL2020000175A patent/CL2020000175A1/es unknown
- 2020-02-11 ZA ZA2020/00881A patent/ZA202000881B/en unknown
- 2020-02-18 CO CONC2020/0001792A patent/CO2020001792A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527431A5 (https=) | ||
| JP2017529838A5 (https=) | ||
| TWI436770B (zh) | 包含專一性辨識ｃｄ３８之抗體及阿糖胞苷（ｃｙｔａｒａｂｉｎｅ）之抗腫瘤組合 | |
| CN105636986B (zh) | 包含vegf拮抗剂和抗-ctla-4抗体的组合的方法和组合物 | |
| JP2025011178A5 (https=) | ||
| JP2014502955A5 (https=) | ||
| JP2020504723A5 (https=) | ||
| JP2020508317A5 (https=) | ||
| JP2020502271A5 (https=) | ||
| JP2018534933A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2017186337A5 (https=) | ||
| JP2020527332A5 (https=) | ||
| JP2021510736A5 (https=) | ||
| FI3932951T3 (fi) | Menetelmiä ihosyövän hoitamiseksi antamalla PD-1-inhibiittoria | |
| JP2019506403A5 (https=) | ||
| CN111278861A (zh) | Pd-l1抗体、其抗原结合片段及医药用途 | |
| JP2009521496A5 (https=) | ||
| FI3810281T3 (fi) | Menetelmiä syövän hoitamiseksi bispesifisillä anti-CD3XMUC16-vasta-aineilla ja anti-PD-1-vasta-aineilla | |
| JP2010526028A5 (https=) | ||
| JPWO2019246514A5 (https=) | ||
| JP2015520758A5 (https=) | ||
| JP2010531140A5 (https=) | ||
| JP2025026572A5 (https=) | ||
| RU2018122629A (ru) | Антитела против 5t4 и конъюгаты антитело-лекарственное средство |